Y-mAbs Therapeutics GAAP EPS of -$1.28 misses by $0.59, revenue of $34.9M beats by $24.08M
25 February 2022 - 8:13AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Y mAbs Therapeutics (NASDAQ:YMAB)
Historical Stock Chart
From Apr 2024 to May 2024
Y mAbs Therapeutics (NASDAQ:YMAB)
Historical Stock Chart
From May 2023 to May 2024